Mitochondrial dysfunction is often linked to neurotoxicity
and
neurological diseases and stems from oxidative stress, yet effective
therapies are lacking. Deoxynivalenol (DON or vomitoxin) is one of
the most common and hazardous type-B trichothecene mycotoxins, which
contaminates crops used for food and animal feed. Despite the abundance
of preliminary reports, comprehensive investigations are scarce to
explore the relationship between these fungal metabolites and neurodegenerative
disorders. The present study aimed to elucidate the precise role of
DON in mitochondrial dynamics and cell death in neuronal cells. Excessive
mitochondrial fission is associated with the pathology of several
neurodegenerative diseases. Human SH-SY5Y cells were treated with
different concentrations of DON (250–1000 ng/mL). Post 24 and
48 h DON treatment, the indexes were measured as follows: generation
of reactive oxygen species (ROS), ATP levels, mitochondrial membrane
potential, calcium levels, and cytotoxicity in SH-SY5Y cells. The
results showed that cytotoxicity, intracellular calcium levels, and
ROS in the DON-treated group increased, while the ATP levels and mitochondrial
membrane potential decreased in a dose-dependent manner. With increasing
DON concentrations, the expression levels of P-Drp-1, mitochondrial
fission proteins Mff, and Fis-1 were elevated with reduced activities
of MFN1, MFN2, and OPA1, further resulting in an increased expression
of autophagic marker LC3 and beclin-1. The reciprocal relationship
between mitochondrial damage and ROS generation is evident as ROS
can instigate structural and functional deficiencies within the mitochondria.
Consequently, the impaired mitochondria facilitate the release of
ROS, thereby intensifying the cycle of damage and exacerbating the
overall process. Using specific hydroxyl, superoxide inhibitors, and
calcium chelators, our study confirmed that ROS and Ca2+-mediated
signaling pathways played essential roles in DON-induced Drp1 phosphorylation.
Therefore, ROS and mitochondrial fission inhibitors could provide
critical research tools for drug development in mycotoxin-induced
neurodegenerative diseases.